Skip to content

Analysis of clinical situation and treatment patterns in CIDP patients based on claims data in Japan

Analysis of clinical situation and treatment patterns in CIDP patients based on claims data in Japan - Analysis of clinical situation and treatment patterns in CIDP patients based on claims data in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000046505
Enrollment
4500
Registered
2021-12-29
Start date
2021-09-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Interventions

None listed

Sponsors

CSL Behring K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet the following criteria are the subjects of this study. Patients who meet the following criteria in the MDV database between April 13, 2008 and August 31, 2018. Patients with ICD-10 code: G618 and classified as CIDP during the data period (excluding multifocal motor neuropathy (MMN)).

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
The percentage of patients examined with each diagnostic test leading up to the CIDP diagnosis. The percentage of CIDP patients treated with each treatment (IVIg, Steroids, Plasma exchange, Immunosuppressants).

Secondary

MeasureTime frame
Treatment patterns of CIDP patients in clinical practice in Japan. Diseases that need to be differentiated from CIDP and actual conditions of CIDP diagnosis.

Countries

Japan

Contacts

Public ContactEr-Win Hew

CSL Behring K.K. Medical Affairs

JPN.Medical_Affairs@cslbehring.com03-4213-0260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026